Probiotics may modestly improve eczema symptoms, but the benefits are smaller than most people expect and depend heavily on which strain you take, how long you take it, and whether you’re trying to prevent eczema or treat it. The strongest evidence supports using certain probiotic strains during pregnancy and breastfeeding to reduce eczema risk in high-risk infants. For adults already living with eczema, the picture is more mixed: overall disease severity scores improve, but individual symptoms like itch and skin roughness often don’t change significantly.
How Gut Bacteria Influence Your Skin
The connection between your gut and your skin isn’t intuitive, but it’s real. More than 70% of your immune cells live in the tissue lining your gut. When you swallow a probiotic, those bacteria interact with immune cells in your intestinal wall, potentially shifting the balance between inflammation-promoting and inflammation-calming signals throughout your body.
Eczema involves an immune system tilt toward overproduction of certain inflammatory molecules, which drives up levels of the antibody IgE and makes skin more hospitable to harmful bacteria like Staphylococcus aureus. Probiotics can stimulate your gut’s immune tissue to produce anti-inflammatory signals that help restore balance between inflammatory and regulatory immune cells. In simple terms, they may help dial down the overreaction that fuels eczema flares.
Gut bacteria also produce short-chain fatty acids (compounds like butyrate, propionate, and acetate) that have broad anti-inflammatory effects. Certain Lactobacillus and Bifidobacterium species can produce GABA, a chemical that inhibits the itch sensation in skin. One study in mice found that Bifidobacterium animalis increased levels of a metabolite called kynurenic acid, which reduced scratching behavior. These pathways help explain why what happens in your gut can show up on your skin, but the effects in humans are still being quantified.
Preventing Eczema in Babies
The most studied use of probiotics for eczema is prevention in infants at high risk (meaning they have a parent or sibling with eczema, asthma, or allergies). A 2015 systematic review found meaningful reductions in eczema risk when probiotics were given to women during the last trimester of pregnancy (29% lower risk), to breastfeeding mothers (43% lower risk), or directly to infants (20% lower risk). That review looked across 12 different probiotic strains and combinations.
Timing matters a great deal. The strongest results come from studies where both the mother and baby received probiotics. In a Finnish trial, pregnant women who took Lactobacillus rhamnosus GG (LGG) daily and continued giving it to their newborns saw lower rates of eczema at age two, with benefits persisting beyond infancy. But when researchers tried prenatal supplementation alone, without continuing after birth, it had no effect on eczema risk. And when a U.S. trial (the TIPS Study) gave LGG only to infants for the first six months, eczema rates looked better at six months (6.6% vs. 15.4%) but were nearly identical by age two (28.7% vs. 30.9%). The early advantage disappeared.
A meta-analysis focused specifically on LGG concluded it was ineffective for eczema prevention on its own. This suggests the benefit seen in broader reviews comes from specific strain combinations or from the prenatal-plus-postnatal approach rather than from any single “best” probiotic.
Treating Eczema in Adults
If you already have eczema, the question shifts from prevention to symptom relief. A meta-analysis of six randomized controlled trials in adults found that probiotics reduced overall disease severity scores by a statistically significant margin. Quality of life also improved. However, when researchers looked at individual symptoms like skin severity and itch severity separately, neither showed a significant change. That’s a somewhat puzzling disconnect: the composite score improved, but the specific symptoms didn’t clearly budge on their own.
The most promising adult trials used multi-strain combinations. One study using Lactobacillus salivarius paired with Bifidobacterium breve showed significant reductions in disease severity that persisted even after participants stopped taking the supplement. Treatment durations in clinical trials ranged from 4 to 24 weeks, and the results generally took time to appear. A 2025 meta-analysis of 13 pediatric trials echoed this: no significant improvement within the first two months, but a meaningful reduction in severity scores after two months of supplementation.
The practical takeaway is that probiotics are not a fast-acting treatment. If they’re going to help, you’ll likely need at least eight to twelve weeks before noticing a difference. And the benefit, while real in some studies, is modest. Probiotics are not replacing moisturizers, topical treatments, or trigger avoidance anytime soon.
Which Strains Have the Best Evidence
Not all probiotics are interchangeable. Different strains produce different immune responses, and a strain that helps one condition may do nothing for another. For eczema specifically, the strains with the most clinical data include:
- Lactobacillus rhamnosus GG (LGG): The most studied single strain for eczema prevention. Results are mixed when used alone, but it shows benefits in combination with prenatal supplementation.
- Bifidobacterium breve: Used in combination trials for adult eczema treatment, with evidence of reduced severity scores.
- Lactobacillus salivarius: Paired with B. breve in one of the more successful adult treatment trials.
- Multi-strain combinations: Broader reviews suggest combinations may outperform single strains, though no one formula has emerged as clearly superior.
The minimum effective dose across clinical trials is generally considered to be at least 1 billion colony-forming units (CFU) per day, though most studies used 10 billion CFU daily. Many commercial probiotic supplements meet this threshold, but the strain listed on the label matters more than the total CFU count.
Topical Probiotics for Eczema
A newer approach skips the gut entirely and applies beneficial bacteria directly to the skin. Researchers at the National Institute of Allergy and Infectious Diseases found that a bacterium called Roseomonas mucosa can help restore protective fats in the skin that people with eczema tend to lack. Skin barrier function also improved. This research has led to an over-the-counter topical probiotic product, though the evidence base is still much thinner than for oral probiotics. The idea is that rebalancing the skin’s own microbial community could complement or simplify standard eczema care.
Safety and Side Effects
For most people, probiotics are well tolerated. Across pooled clinical trial data involving hundreds of participants, gastrointestinal side effects (diarrhea, constipation, abdominal cramping) occurred at similar rates in probiotic and placebo groups. A Cochrane review found no evidence of increased adverse effects from probiotic use during eczema trials.
That said, rare but serious complications have been reported outside of controlled trials. Case reports have documented bloodstream infections (sepsis) linked to probiotic use, including one fatal case. These events occurred in people who were critically ill, immunocompromised, or recovering from surgery. For an otherwise healthy person with eczema, the risk is extremely low. But if you have a weakened immune system or are seriously ill for other reasons, probiotics carry a small but real risk that’s worth discussing with your care team.
In infants, some parents in trials reported green loose stools, increased spitting up, or feed refusal, though it was often unclear whether these issues came from the probiotic itself or from the formula it was mixed into. About 17% of parents in one trial stopped the formula altogether due to these difficulties.
What This Means in Practice
Probiotics are not a cure for eczema and are unlikely to replace your current management plan. They’re best understood as a potential add-on that may reduce overall disease severity by a modest amount, particularly after two or more months of consistent use. The strongest case for probiotics is in eczema prevention for high-risk infants when supplementation starts during pregnancy and continues after birth.
If you’re considering trying probiotics for existing eczema, choose a product that contains well-studied strains (Lactobacillus or Bifidobacterium species) at a dose of at least 1 billion CFU, give it at least eight weeks, and keep realistic expectations. Some people notice meaningful improvement in overall comfort and quality of life. Others see no change at all. The research supports probiotics as a plausible, low-risk option, not a reliable one.